Hepatitis C

Priority Healthcare Corp. selected as the distributor for Pegasys Sampling Program

Published in Hepatitis Weekly, December 9th, 2002

Priority Healthcare Corp. (PHCC) announced their selection by Roche Labs as the distributor for the Pegasys Monotherapy Sampling Program.

Pegasys is Roche's pegylated interferon alfa-2a for hepatitis C treatment that has received FDA approval. The program will provide samples to physicians to treat approximately 15,000 patients over the first 12 weeks of therapy.

After this point, responding patients will seek public or private reimbursement to complete the course of therapy. The Pegasys samples will be distributed from Priority Healthcare's Grove City, Ohio, distribution facility.

Priority Healthcare Corp. is a national...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2002-12-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry